A highly specific and sensitive serological assay detects SARS‑CoV‑2 antibody levels in COVID‑19 patients that correlate with neutralization

URN to cite this document:: urn:nbn:de:bvb:355-epub-446629
DOI to cite this document:: 10.5283/epub.44662

Peterhoff, David

; Glück, Vivian ; Vogel, Matthias ; Schuster, Philipp ; Schütz, Anja ; Neubert, Philip ; Albert, Veruschka ; Frisch, Stefanie ; Kiessling, Mara ; Pervan, Philip ; Werner, Maren ; Ritter, Nicole ; Babl, Leon ; Deichner, Maria ; Hanses, Frank ; Lubnow, Matthias ; Müller, Thomas ; Lunz, Dirk ; Hitzenbichler, Florian ; Audebert, Franz ; Hähnel, Viola ; Offner, Robert ; Müller, Martina ; Schmid, Stephan ; Burkhardt, Ralph

; Glück, Thomas ; Koller, Michael ; Niller, Hans Helmut ; Graf, Bernhard ; Salzberger, Bernd ; Wenzel, Jürgen J.

; Jantsch, Jonathan ; Gessner, André

; Schmidt, Barbara ; Wagner, Ralf

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(2MB)

Date of publication of this fulltext: 02 Feb 2021 14:10

Alternative links to fulltext:DOI Publisher

This publication is part of the DEAL contract with Springer.

Details

Preview

Indexed in

Export bibliographical data

Abstract

Objective The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic challenges national health systems and the global economy. Monitoring of infection rates and seroprevalence can guide public health measures to combat the pandemic. This depends on reliable tests on active and former infections. Here, we set out to develop and validate a specific and sensitive enzyme linked ...